RBX1 and Miyoshi myopathy: To test the hypothesis that MM cells with high RBX1 expression are more drug-resistance and responsible for MM relapse, cells were then grown in the presence or absence of doxorubicin (Dox) at a dose of 100 nM for 48 h.